Siegel L K, Klingbeil M A
Medical College of Wisconsin.
Dev Med Child Neurol. 1991 Nov;33(11):1013-4. doi: 10.1111/j.1469-8749.1991.tb14818.x.
Transdermal scopolamine patches (1.5 mg) were used to control drooling in a two-year-old boy with severe spastic quadriparetic cerebral palsy and developmental delay. He responded well to the continuous scopolamine therapy, with a decrease in drooling, and a secondary decrease in respiratory distress and frequency of suctioning. No significant side-effects were noted.
透皮东莨菪碱贴片（1.5毫克）用于控制一名患有严重痉挛性四肢瘫脑瘫和发育迟缓的两岁男孩的流口水症状。他对持续的东莨菪碱治疗反应良好，流口水症状减轻，呼吸窘迫和吸痰频率也随之降低。未观察到明显的副作用。
